We report a case of acute respiratory distress syndrome associated with eosinophilic pneumonia in an adolescent with acute Epstein-Barr viral infection.
Get full access to this article
View all access options for this article.
References
1.
AlpH, DaumR, AbrahamsC, WylamM. Acute eosinophilic pneumonia: a cause of reversible, severe, noninfectious respiratory failure. J Pediatr, 1998; 132:540–543.
2.
AndimanW, MarkowitzR, HorstmannD. Clinical, virologic, and serologic evidence of Epstein-Barr virus infection in association with childhood pneumonia. J Pediatr, 1981; 99:880–886.
3.
CarsinA, BosdureE, ZandottiC, ManciniJ, CharbrolB, DubusJC. Severe bronchopneumonia in children: can Epstein-Barr virus serology be misleading?Arch Pediatr, 2008; 15:1667–1671.
4.
CostaC, EliaM, AstegianoS, SidotiF, TerlizziME, SolidoroPet al.Quantitative detection of Epstein-Barr virus in bronchoalveolar lavage from transplant and nontransplant patients. Transplantation, 2008; 86:1389–1394.
5.
ManikaD, Alexiou-DanielS, PapakostaD, PapaA, KontakiotisT, PatakasDet al.Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis, 2007; 24:134–140.
6.
GrinnanD, SungS, DoughertyJ, KnowlesA, AllenM, RoseCet al.Enhanced allergen-induced airway inflammation in paucity of lymph node T cell (plt) mutant mice. J Allergy Clin Immunol, 2006; 118:1234–1241.
7.
SalamaME, ParhamDM, PerkinsSL, BahlerDW, EllisonDA. Fatal non-transplant-related Epstein-Barr virus-associated atypical lymphoid proliferations in infants and children: a clinicopathologic study. Pediatr Dev Pathol, 2008; 11:443–449.
8.
OttG, OttMM, FellerAC, SeidlSet al.Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a european population. Int J Cancer, 1992; 51:562–567.
9.
HislopA, PalendiraU, LeeseA, ArkwrightP, RohrlichP, TangyeSet al.Impaired Epstein-Barr virus-specific CD8+ T-cell function in x-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood, 2010; 116:3249–3257.
10.
KawaguchiM, KokubuF, KugaH, TomitaT, MatsukuraS, KadokuraMet al.Expression of eotaxin by normal airway epithelial cells after influenza virus A infection. Int Arch Allergy Immunol, 2000; 122:44–49.
11.
MatsukuraS, KokubuF, KuboH, TomitaT, TokunagaH, KadokuraMet al.Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol, 1998; 18:255–264.
12.
RosenbergHF, DomachowskiJB. Eosinophils, eosinophil ribonucleases and their role in host defense against respiratory virus pathogens. J Leukoc Biol, 2001; 70:691–698.
13.
DomachowskeJB, DyerKD, BonvilleCA, RosengergHF. Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis, 1998; 177:1458–1464.
14.
PhippsS, LamCE, MahalingamS, NewhouseM, RamirezR, RosengergHFet al.Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood, 2007; 110:1578–1586.
15.
JanzDR, O'NealHR, ElyEW. Acute eosinophilic pneumonia: acase report and review of the literature. Crit Care Med, 2009; 37:1470–1474.
16.
TerzanoC, PetroianniP. Clarithromycin and pulmonary infiltration with eosinophilia. BMJ, 2003; 326:1377–1378.
ShioharaT, InaokaM, KanoY. Drug–induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay amoung herpesviruses and antiviral and antidrug immune responses. Allergol Int, 2006; 55:1–8.
21.
KanoY, ShioharaT. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin N Am, 2009; 29:481–501.
22.
ShioharaT, KanoY. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol, 2007; 33:124–133.
